132 related articles for article (PubMed ID: 15862352)
1. Screening enzyme-inhibitory activity in several ascidian species from Orkney Islands using protein tyrosine kinase (PTK) bioassay-guided fractionation.
Barenbrock JS; Köck M
J Biotechnol; 2005 May; 117(3):225-32. PubMed ID: 15862352
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.
Ben-Bassat H
Curr Opin Investig Drugs; 2001 Nov; 2(11):1539-45. PubMed ID: 11763154
[TBL] [Abstract][Full Text] [Related]
3. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
4. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
Gazit A; Osherov N; Gilon C; Levitzki A
J Med Chem; 1996 Dec; 39(25):4905-11. PubMed ID: 8960549
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
6. Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolones.
Traxler P; Green J; Mett H; Séquin U; Furet P
J Med Chem; 1999 Mar; 42(6):1018-26. PubMed ID: 10090785
[TBL] [Abstract][Full Text] [Related]
7. Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor.
Liechti C; Séquin U; Bold G; Furet P; Meyer T; Traxler P
Eur J Med Chem; 2004 Jan; 39(1):11-26. PubMed ID: 14987830
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases.
Asano T; Nakamura H; Uehara Y; Yamamoto Y
Chembiochem; 2004 Apr; 5(4):483-90. PubMed ID: 15185372
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a new series of phenylhydroquinone derivatives as inhibitors of EGF-R-associated PTK activity.
Million ME; Mailliett P; Chen H; Bashiardes G; Boiziau J; Parker F; Commerçon A; Tocque B; Roques BP; Garbay C
Anticancer Drug Des; 1996 Mar; 11(2):129-53. PubMed ID: 8630186
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
[TBL] [Abstract][Full Text] [Related]
11. [Natural tyrosine-kinase inhibitors].
Le Cam A
Pathol Biol (Paris); 1991 Oct; 39(8):796-800. PubMed ID: 1762839
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-ones.
Xiao ZP; Li HQ; Shi L; Lv PC; Song ZC; Zhu HL
ChemMedChem; 2008 Jul; 3(7):1077-82. PubMed ID: 18433075
[TBL] [Abstract][Full Text] [Related]
13. Acryloylamino-salicylanilides as EGFR PTK inhibitors.
Deng W; Guo Z; Guo Y; Feng Z; Jiang Y; Chu F
Bioorg Med Chem Lett; 2006 Jan; 16(2):469-72. PubMed ID: 16275081
[TBL] [Abstract][Full Text] [Related]
14. Hexa-, hepta- and nonaprenylhydroquinones isolated from marine sponges Sarcotragus muscarum and Ircinia fasciculata inhibit NF-kappaB signalling in H4IIE cells.
Wätjen W; Putz A; Chovolou Y; Kampkötter A; Totzke F; Kubbutat MH; Proksch P; Konuklugil B
J Pharm Pharmacol; 2009 Jul; 61(7):919-24. PubMed ID: 19589234
[TBL] [Abstract][Full Text] [Related]
15. MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull.
Saaby L; Rasmussen HB; Jäger AK
J Ethnopharmacol; 2009 Jan; 121(1):178-81. PubMed ID: 19013512
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of N-coumaroyltyramine as a potent phytochemical which arrests human transformed cells via inhibiting protein tyrosine kinases.
Park JB; Schoene N
Biochem Biophys Res Commun; 2002 Apr; 292(4):1104-10. PubMed ID: 11944930
[TBL] [Abstract][Full Text] [Related]
17. Structural and electronic properties of tyrosine kinases inhibitors.
Santillán MB; Tomás-Vert F; Aulló JM; Jáuregui EA; Ciuffo GM
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):929-37. PubMed ID: 14656050
[TBL] [Abstract][Full Text] [Related]
18. In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells.
Cavasotto CN; Ortiz MA; Abagyan RA; Piedrafita FJ
Bioorg Med Chem Lett; 2006 Apr; 16(7):1969-74. PubMed ID: 16413185
[TBL] [Abstract][Full Text] [Related]
19. Detection of protein tyrosine kinase activity using a high-capacity streptavidin-coated membrane and optimized biotinylated peptide substrates.
Schaefer EM; Guimond S
Anal Biochem; 1998 Jul; 261(1):100-12. PubMed ID: 9683518
[TBL] [Abstract][Full Text] [Related]
20. Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.
Lee KI; Park Y; Park SJ; Hwang JH; Lee SJ; Kim GD; Park WK; Lee S; Jeong D; Kong JY; Kang HK; Cho H
Bioorg Med Chem Lett; 2006 Feb; 16(3):737-42. PubMed ID: 16321529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
